Vaccines for preventing herpes zoster in older adults.

CONCLUSIONS: LZV and RZV are effective in preventing herpes zoster disease for up to three years (the main studies did not follow participants for more than three years). To date, there are no data to recommend revaccination after receiving the basic schedule for each type of vaccine. Both vaccines produce systemic and injection site adverse events of mild to moderate intensity. PMID: 31696946 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31696946?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - November 6, 2019 Category: General Medicine Authors: Gagliardi AM, Andriolo BN, Torloni MR, Soares BG, de Oliveira Gomes J, Andriolo RB, Canteiro Cruz E Tags: Cochrane Database Syst Rev Source Type: research